Fellow of the Royal Society of South Africa
Kelly Chibale spends much of his time researching Stereochemistry, Plasmodium falciparum, Pharmacology, In vitro and Malaria. His Stereochemistry research incorporates elements of Combinatorial chemistry, Quinoline, Chemical synthesis and Antimycobacterial. His Plasmodium falciparum study combines topics from a wide range of disciplines, such as Biochemistry, Structure–activity relationship, Cysteine protease and Cytotoxicity.
The Pharmacology study combines topics in areas such as Chloroquine, Artemisinin, In vivo and Plasmodium berghei. His studies deal with areas such as Chalcone and Strain as well as In vitro. His Malaria research incorporates themes from Environmental health, Virology, African trypanosomiasis, Drug resistance and Drug discovery.
His primary areas of study are Plasmodium falciparum, Stereochemistry, Pharmacology, In vitro and Biochemistry. Kelly Chibale works mostly in the field of Plasmodium falciparum, limiting it down to topics relating to Structure–activity relationship and, in certain cases, Parasite hosting, as a part of the same area of interest. His Stereochemistry research includes themes of Antimycobacterial, Quinoline and Chemical synthesis.
His study in Pharmacology is interdisciplinary in nature, drawing from both Metabolite, Hemozoin, In vivo and Plasmodium berghei. His studies in In vitro integrate themes in fields like Mode of action and Strain. His study looks at the relationship between Biochemistry and fields such as Mycobacterium tuberculosis, as well as how they intersect with chemical problems.
Kelly Chibale mainly investigates Plasmodium falciparum, Malaria, In vivo, Pharmacology and Drug discovery. The various areas that Kelly Chibale examines in his Plasmodium falciparum study include Mode of action, Chloroquine, Benzimidazole and Cytotoxicity. His research ties Stereochemistry and Cytotoxicity together.
His Malaria research is multidisciplinary, incorporating perspectives in Humanized mouse and Virology. His research in In vivo intersects with topics in Multiple drug resistance, In vitro, ADME, hERG and Kinase. Kelly Chibale combines subjects such as Intensive care medicine, Druggability, Artemisinin, Computational biology and Drug with his study of Drug discovery.
His primary scientific interests are in Plasmodium falciparum, Drug discovery, Malaria, Pharmacology and Microsome. The study incorporates disciplines such as Combinatorial chemistry, Chloroquine, Stereochemistry and Quinoline in addition to Plasmodium falciparum. Borrowing concepts from Bioorganometallic chemistry, Kelly Chibale weaves in ideas under Stereochemistry.
His research integrates issues of Humanized mouse and Drug in his study of Malaria. He interconnects Mediator, Kinase and In vivo in the investigation of issues within Pharmacology. His Microsome study integrates concerns from other disciplines, such as Mechanism of action, Structure–activity relationship and Mycobacterium tuberculosis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi.
Doron C. Greenbaum;Zachary Mackey;Elizabeth Hansell;Patricia Doyle.
Journal of Medicinal Chemistry (2004)
Design, synthesis and in vitro antimalarial evaluation of triazole-linked chalcone and dienone hybrid compounds
Eric M. Guantai;Kanyile Ncokazi;Timothy J. Egan;Jiri Gut.
Bioorganic & Medicinal Chemistry (2010)
Exploring the potential of xanthene derivatives as trypanothione reductase inhibitors and chloroquine potentiating agents
Kelly Chibale;Mark Visser;Donelly van Schalkwyk;Peter J Smith.
Tetrahedron (2003)
Design, synthesis and anti-plasmodial evaluation in vitro of new 4-aminoquinoline isatin derivatives
Idan Chiyanzu;Cailean Clarkson;Peter J. Smith;Julie Lehman.
Bioorganic & Medicinal Chemistry (2005)
The state of the art in anti-malarial drug discovery and development.
Jeremy N. Burrows;Kelly Chibale;Timothy N.C. Wells.
Current Topics in Medicinal Chemistry (2011)
Synthesis, antimalarial and antitubercular activity of acetylenic chalcones
Renate H. Hans;Eric M. Guantai;Carmen Lategan;Peter J. Smith.
Bioorganic & Medicinal Chemistry Letters (2010)
Synthesis and evaluation of isatins and thiosemicarbazone derivatives against cruzain, falcipain-2 and rhodesain.
Idan Chiyanzu;Elizabeth Hansell;Jiri Gut;Philip J. Rosenthal.
Bioorganic & Medicinal Chemistry Letters (2003)
Novel web-based tools combining chemistry informatics, biology and social networks for drug discovery.
Moses Hohman;Kellan Gregory;Kelly Chibale;Peter J. Smith.
Drug Discovery Today (2009)
Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase
Tanya Paquet;Claire Le Manach;Diego González Cabrera;Yassir Younis.
Science Translational Medicine (2017)
3,5-Diaryl-2-aminopyridines as a Novel Class of Orally Active Antimalarials Demonstrating Single Dose Cure in Mice and Clinical Candidate Potential
Yassir Younis;Frederic Douelle;Tzu-Shean Feng;Diego Gonzalez Cabrera.
Journal of Medicinal Chemistry (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Aberdeen
Swiss Tropical and Public Health Institute
University of California, San Francisco
Ghent University
London School of Hygiene & Tropical Medicine
Rice University
University of California, San Diego
University of Illinois at Chicago
Columbia University
University of California, San Diego
City College of New York
Weizmann Institute of Science
National University of Singapore
Aristotle University of Thessaloniki
Tufts University
University of California, San Francisco
Spanish National Research Council
Inserm : Institut national de la santé et de la recherche médicale
Institute of Tropical Medicine Antwerp
University of Gothenburg
Centre national de la recherche scientifique, CNRS
University of New Hampshire
Tsinghua University
St. Jude Children's Research Hospital
Ghent University Hospital
National Institute for Astrophysics